Is it necessary to distinguish between combined hepatocellular carcinoma-cholangiocarcinoma with less than 10% of cholangiocarcinoma components versus hepatocellular carcinoma?
Crossref DOI link: https://doi.org/10.1007/s12072-025-10817-3
Published Online: 2025-04-30
Published Print: 2025-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paradis, V.
Text and Data Mining valid from 2025-04-30
Version of Record valid from 2025-04-30
Article History
Received: 20 January 2025
Accepted: 1 March 2025
First Online: 30 April 2025
Free to read: This content has been made available to all.